PharmFormulator is a source-linked research platform with over 1,200 U.S. ophthalmic drug-product records, including ...
WeGuide Pty Ltd will receive A$1.9 million to build a world first platform in developing commercial multi-modal biomarkers.
Kyverna Therapeutics' miv-cel showed improved mobility and a favorable safety profile at one year in patients with stiff ...
Beijing, China, September 24, 2026 — Pulmongene Ltd. (“Pulmongene” or “the Company”), a clinical-stage biotechnology company ...
While Acadia Pharmaceuticals’ candidate has missed the main goal of a Phase 2 trial, the company is still moving forward with the anti-psychosis candidate in Alzheimer’s disease as well as Lewy body ...
ARCT-810 generally safe and well tolerated, demonstrating encouraging activity across key urea cycle biomarkers in ongoing ...
While artificial intelligence can help biotech and pharma companies more quickly vet job applicants, it can also turn off the ...
The weekly insulin Onswik will now be available to U.S. patients after initial approvals in Europe, Mexico and Japan.
Basecamp Research joins the growing group of AI-forward biotechs that in recent months have brought in notable sums from investors, including Isomorphic Labs and Enveda.
In this episode of Denatured presented by Curium, Jennifer Smith-Parker speaks to Mike Patterson, CEO North America and Professor Sabine Brookman-May, vice president and head of Global Clinical ...
Analysts were keen to see a new modality compete with Roche’s approved drug Lucentis in the late-stage trial but new safety issues could complicate the future for Merck’s candidate.
Gossamer Bio is a biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results